Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,433 public trials 838 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis

NCT00004287

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Growth Hormone Use in Cystic Fibrosis - a Multicenter Study

NCT00005112

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University of Texas Medical School Houston, Texas, United States

University of Utah, Dept of Pediatric Endocrinology Salt Lake City, Utah, United States

View Trial Details

Terminated

TCR-T Cell Therapy on Advanced Solid Tumors

NCT05438667

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China

View Trial Details

Terminated

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

NCT06091930

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +26 more
Locations: National Cancer Center Hospital East Chiba, Kashiwa, Japan

National Cancer Center Hospital Tokyo, Chuo-ku, Japan

Japanese Foundation for Cancer Research Tokyo, Koto-ku, Japan

View Trial Details

Terminated

Early Screening of Pancreatic Lesions : Development of New Imaging Tools

NCT04007640

Conditions: Body Weight, Diabetes Mellitus, Digestive System Diseases, +20 more
Locations: Hôpital Beaujon Clichy, France

View Trial Details

Suspended

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

NCT05685602

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

View all 26 locations

View Trial Details

Suspended

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

NCT06202066

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Suspended

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

NCT05494697

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Nebraska Medical Center Omaha, Nebraska, United States

Gabrail Cancer Center Research Canton, Ohio, United States

Virginia Mason Medical Center Seattle, Washington, United States

View Trial Details

Suspended

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

NCT05873699

Conditions: Cysts, Digestive System Diseases, Neoplasms, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Withdrawn

IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations

NCT06487377

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
Locations: Shanghai Pudong Hospital Shanghai, Shanghai Municipality, China

View Trial Details